NCT03493945 2025-09-30
Phase I/II Study of Immunotherapy Combination BN-Brachyury Vaccine, M7824, N-803 and Epacadostat (QuEST1)
National Institutes of Health Clinical Center (CC)
Phase 1/2 Completed
Clinical Trials
9 trialsNCT00924027 2025-09-05
A Study of Patients Receiving High-Dose Rate Brachytherapy
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT03315871 2025-06-19
Combination Immunotherapy in Biochemically Recurrent Prostate Cancer
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT02681614 2022-06-30
Pilot Study Evaluating the Role of Histopathology Correlation in Treatment Planning
Case Comprehensive Cancer Center
Phase NA Completed
NCT02611882 2020-12-22
PSMA PET
University of California, San Francisco
Phase 2 Completed
NCT02470910 2019-12-11
Incorporating MR Imaging Into Prostate Radiotherapy Treatment Planning
Dana-Farber Cancer Institute
Phase NA Completed
NCT02141490 2019-09-06
Study of Ferumoxytol Enhanced MRI for Detecting Lymph Node Metastases in Prostate, Bladder, and Kidney Cancers
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT00851682 2018-10-31
Feasibility Study of Prostate Tumor Localization for Focal Cryoablation of Prostate Carcinoma
Washington University School of Medicine
Phase NA Terminated
NCT01357512 2017-12-02
Evaluation of Diagnostic Value of 3-T Magnetic Resonance Imaging (MRI) in Suspected Prostate Cancer
University of Oulu
Phase NA Completed